Stereological investigation of the effects of curcumin on the damage in the hippocampus of developing rat brain caused by valproic acid
Abstract
Valproic acid is an antiepileptic drug used for the treatment of seizures in newborns, children and adults. Despite having positive effect in the treatment of epilepsy, valproic acid may adversely affect brain function and brain development. Antioxidant and neuroprotective properties of curcumin are well-known. Curcumin has a significant effect in the treatment of various diseases caused by oxidative stress. In the light of this information, the study aimed to determine the adverse effects of valproic acid in the number of pyramidal cells in the hippocampus of the developing rat brain and whether curcumin has protective effects against these adverse effects. A total of 50 Wistar male rats were divided into two groups as 7 and 14 day old. Each group was subdivided into five groups as control, curcumin, dimethyl sulfoxide, valproic acid, valproic acid+curcumin. After dissolving in 10% dimethylsulfoxide, the rats in each group received intraperitoneal injection of valproic acid (400 mg/kg) and curcumin (200 mg/kg). Rats were sacrificed 24 hours after the last injection. After histological processes, stereological analysis was performed using optical fractionation technique. Overall number of neurons in the left hippocampus (CA1, CA2, CA3 and CA4) of the 7 and 14 day old rats was estimated and average numerical values were determined. The mean total neuron numbers and standard deviations for 7 day old rats were 727224±4531.7 in control group; 312232.8±15853.3 in valproic acid group and 431665.4±28464.5 in valproic acid+curcumin group. These numerical values were 508160.6±21985.2; 313958.9±18199.66 and 456028.8±24942.9 for 14 day old rats respectively. The results support the idea that curcumin can be a potential protective and effective agent in the prevention of histological neuronal damage that may occur in the developing rat brain due to valproic acid treatment. We are in the opinion that the results of this study will shed light on clinical studies and form a basis to antioxidant studies involving the use of valproric acid. |
Details
| Primary Language | English |
|---|---|
| Journal Section | Basic Medical Sciences |
| Authors | |
| Publication Date | September 10, 2014 |
| Submission Date | September 10, 2014 |
| Published in Issue | Year 2014 Volume: 31 Issue: 2 |
Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.